SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-004282
Filing Date
2023-03-21
Accepted
2023-03-21 16:18:19
Documents
12
Period of Report
2023-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20230313x8k.htm   iXBRL 8-K 29589
  Complete submission text file 0001558370-23-004282.txt   144841

Data Files

Seq Description Document Type Size
2 EX-101.SCH rsls-20230313.xsd EX-101.SCH 3105
3 EX-101.LAB rsls-20230313_lab.xml EX-101.LAB 15240
4 EX-101.PRE rsls-20230313_pre.xml EX-101.PRE 9781
6 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20230313x8k_htm.xml XML 4669
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 23749937
SIC: 3841 Surgical & Medical Instruments & Apparatus